Detailed answers about GIBLIN BROS. (WHOLESALE PHARMACEUTICALS) LIMITED, including incorporation, status, business activity, and accounts information.
When was GIBLIN BROS. (WHOLESALE PHARMACEUTICALS) LIMITED founded?
GIBLIN BROS. (WHOLESALE PHARMACEUTICALS) LIMITED was officially incorporated on 22 May 1951 and is registered under company number 00495671. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is GIBLIN BROS. (WHOLESALE PHARMACEUTICALS) LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of GIBLIN BROS. (WHOLESALE PHARMACEUTICALS) LIMITED?
GIBLIN BROS. (WHOLESALE PHARMACEUTICALS) LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does GIBLIN BROS. (WHOLESALE PHARMACEUTICALS) LIMITED do?
GIBLIN BROS. (WHOLESALE PHARMACEUTICALS) LIMITED operates in the following sector: 99999 - Dormant Company. This provides insight into the company's primary business activity and industry focus.
What is GIBLIN BROS. (WHOLESALE PHARMACEUTICALS) LIMITED's registered address?
The registered office address of GIBLIN BROS. (WHOLESALE PHARMACEUTICALS) LIMITED is P.A. GIBLIN, 11 STATION ROAD, MAGHULL, LIVERPOOL, L31 3DA. This is the official address filed with Companies House for legal and statutory correspondence.
Is GIBLIN BROS. (WHOLESALE PHARMACEUTICALS) LIMITED financially stable?
The most recent accounts for GIBLIN BROS. (WHOLESALE PHARMACEUTICALS) LIMITED were made up to 31 December 2024, filed as DORMANT. Next accounts are due by 30 September 2026.